Print this page    •   Back to Web version of article

International News
Mylan Subsidiary Starts Operations in India

August 9, 2012

Pennsylvania-based Mylan Inc. said a subsidiary has launched commercial operations in India, beginning with HIV/AIDS drugs. After initially offering 18 antiretrovirals, Mylan Pharmaceuticals Private Ltd. plans to add therapeutic categories and enlarge its sales force. Mylan already is active in the nation, having acquired a majority stake in Matrix Laboratories of India in 2007 and bought the remainder of the company in 2009. India is home to the world's third-largest population of HIV/AIDS patients, according to the National AIDS Control Organization.

Back to other news for August 2012

Excerpted from:
Associated Press
08.06.2012



This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/68647/mylan-subsidiary-starts-operations-in-india.html

General Disclaimer: TheBody.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBody.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.